| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.649 | 0.005 | 0.703 | Anticonvulsant | 0.647 0.005 CID_160632 0.419 0.019 CID_160610 0.703 0.005 CID_154699869 | CID_154699869 | |
| 0.597 | 0.013 | 0.693 | Spasmolytic | 0.451 0.03 CID_160632 0.641 0.01 CID_160610 0.693 0.006 CID_154699869 | CID_154699869 | |
| 0.602 | 0.019 | 0.755 | Aldehyde oxidase inhibitor | 0.301 0.066 CID_160632 0.755 0.005 CID_160610 0.495 0.034 CID_154699869 | CID_160610 | |
| 0.548 | 0.02 | 0.738 | 5 Hydroxytryptamine release stimulant | 0.738 0.005 CID_160632 0.581 0.016 CID_160610 0.411 0.044 CID_154699869 | CID_160632 | |
| 0.485 | 0.004 | 0.485 | Nav1.1 sodium channel blocker | 0.441 0.004 CID_160632 0.415 0.004 CID_160610 0.367 0.005 CID_154699869 | ||
| 0.475 | 0.018 | 0.499 | Cardiotonic | 0.389 0.031 CID_160632 0.381 0.032 CID_160610 0.499 0.015 CID_154699869 | CID_154699869 | |
| 0.442 | 0.005 | 0.442 | Nav1.2 sodium channel blocker | 0.41 0.006 CID_160632 0.349 0.01 CID_160610 0.205 0.033 CID_154699869 | ||
| 0.446 | 0.016 | 0.475 | Psychostimulant | 0.475 0.013 CID_160632 0.419 0.019 CID_160610 0.358 0.03 CID_154699869 | CID_160632 | |
| 0.476 | 0.056 | 0.549 | Analgesic | 0.492 0.052 CID_160632 0.398 0.085 CID_160610 0.549 0.037 CID_154699869 | CID_154699869 | |
| 0.443 | 0.043 | 0.48 | Vasodilator, peripheral | 0.35 0.074 CID_160632 0.444 0.042 CID_160610 0.48 0.032 CID_154699869 | CID_154699869 | |
| 0.395 | 0.003 | 0.395 | Sphingomyelinase inhibitor | 0.294 0.004 CID_160632 0.309 0.003 CID_160610 0.273 0.004 CID_154699869 | ||
| 0.433 | 0.058 | 0.492 | Histamine release inhibitor | 0.369 0.091 CID_160632 0.492 0.032 CID_160610 0.414 0.069 CID_154699869 | CID_160610 | |
| 0.371 | 0.005 | 0.371 | Histamine H1 receptor antagonist | 0.22 0.012 CID_160632 0.221 0.012 CID_160610 0.307 0.006 CID_154699869 | ||
| 0.361 | 0.005 | 0.361 | Nav1.3 sodium channel blocker | 0.29 0.01 CID_160632 0.247 0.014 CID_160610 0.161 0.041 CID_154699869 | ||
| 0.35 | 0.009 | 0.35 | Anesthetic local | 0.3 0.012 CID_160632 0.281 0.014 CID_160610 0.232 0.024 CID_154699869 | ||
| 0.377 | 0.044 | 0.384 | Vasodilator, coronary | 0.295 0.092 CID_160632 0.378 0.043 CID_160610 0.384 0.041 CID_154699869 | CID_154699869 | |
| 0.341 | 0.01 | 0.341 | Antipruritic | 0.332 0.01 CID_160632 0.331 0.01 CID_160610 0.208 0.044 CID_154699869 | ||
| 0.391 | 0.066 | 0.401 | GABA C receptor rho-3 antagonist | 0.401 0.061 CID_160632 0.39 0.066 CID_160610 0.207 0.199 CID_154699869 | CID_160632 | |
| 0.329 | 0.005 | 0.329 | Nav1.6 sodium channel blocker | 0.223 0.013 CID_160632 0.252 0.009 CID_160610 0.166 0.038 CID_154699869 | ||
| 0.325 | 0.025 | 0.325 | P-glycoprotein inhibitor | 0.254 0.04 CID_160632 0.306 0.028 CID_160610 0.317 0.026 CID_154699869 | ||
| 0.31 | 0.01 | 0.31 | Antihistaminic | 0.244 0.015 CID_160632 0.144 0.034 CID_160610 0.184 0.024 CID_154699869 | ||
| 0.311 | 0.013 | 0.311 | Acetylcholine M1 receptor antagonist | 0.244 0.027 CID_160632 0.297 0.015 CID_160610 0.23 0.031 CID_154699869 | ||
| 0.3 | 0.01 | 0.3 | Histamine antagonist | 0.234 0.015 CID_160632 0.126 0.036 CID_160610 0.156 0.028 CID_154699869 | ||
| 0.297 | 0.01 | 0.297 | Calcium channel blocker | 0.261 0.015 CID_160632 0.196 0.032 CID_160610 0.144 0.064 CID_154699869 | ||
| 0.392 | 0.108 | 0.447 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.447 0.063 CID_160632 | CID_160632 | |
| 0.304 | 0.03 | 0.323 | Gastrin inhibitor | 0.323 0.02 CID_160632 0.242 0.089 CID_160610 0.247 0.083 CID_154699869 | CID_160632 | |
| 0.288 | 0.038 | 0.288 | 5 Hydroxytryptamine 1E antagonist | 0.283 0.042 CID_160632 0.286 0.04 CID_160610 | ||
| 0.284 | 0.042 | 0.329 | Tyrosine 3 hydroxylase inhibitor | 0.29 0.038 CID_160632 0.329 0.022 CID_160610 0.219 0.104 CID_154699869 | CID_160610 | |
| 0.254 | 0.012 | 0.254 | 5 Hydroxytryptamine 2C antagonist | 0.188 0.019 CID_160632 0.165 0.023 CID_160610 0.073 0.069 CID_154699869 | ||
| 0.254 | 0.017 | 0.34 | Aldehyde dehydrogenase inhibitor | 0.165 0.039 CID_160632 0.34 0.008 CID_160610 0.171 0.037 CID_154699869 | CID_160610 | |
| 0.251 | 0.015 | 0.255 | 5 Hydroxytryptamine 3E antagonist | 0.255 0.014 CID_160632 0.203 0.057 CID_160610 0.168 0.143 CID_154699869 | CID_160632 | |
| 0.275 | 0.04 | 0.286 | Anesthetic general | 0.203 0.073 CID_160632 0.286 0.037 CID_160610 0.228 0.06 CID_154699869 | CID_160610 | |
| 0.265 | 0.043 | 0.265 | Neuropeptide Y2 antagonist | 0.23 0.077 CID_160632 0.257 0.05 CID_160610 | ||
| 0.242 | 0.023 | 0.242 | Cholinergic antagonist | 0.181 0.037 CID_160632 0.216 0.028 CID_160610 0.234 0.024 CID_154699869 | ||
| 0.235 | 0.017 | 0.251 | Alpha 2b adrenoreceptor antagonist | 0.251 0.014 CID_160632 0.209 0.022 CID_160610 | CID_160632 | |
| 0.236 | 0.019 | 0.236 | Antiadrenergic | 0.21 0.023 CID_160632 0.194 0.025 CID_160610 0.138 0.039 CID_154699869 | ||
| 0.221 | 0.005 | 0.325 | Adrenaline uptake inhibitor | 0.325 0.004 CID_160632 0.147 0.009 CID_160610 0.176 0.007 CID_154699869 | CID_160632 | |
| 0.27 | 0.055 | 0.295 | Cyclic AMP phosphodiesterase inhibitor | 0.16 0.135 CID_160632 0.295 0.044 CID_160610 0.173 0.119 CID_154699869 | CID_160610 | |
| 0.22 | 0.006 | 0.26 | Prolactin inhibitor | 0.166 0.016 CID_160632 0.26 0.004 CID_160610 0.144 0.025 CID_154699869 | CID_160610 | |
| 0.305 | 0.091 | 0.443 | Transcription factor NF kappa B inhibitor | 0.323 0.085 CID_160632 0.443 0.054 CID_160610 0.417 0.06 CID_154699869 | CID_160610 | |
| 0.286 | 0.074 | 0.286 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.214 0.142 CID_160632 0.259 0.098 CID_160610 0.191 0.168 CID_154699869 | ||
| 0.354 | 0.142 | 0.445 | Caspase 9 stimulant | 0.318 0.175 CID_160632 0.445 0.086 CID_160610 0.305 0.189 CID_154699869 | CID_160610 | |
| 0.23 | 0.024 | 0.23 | 5 Hydroxytryptamine 2 antagonist | 0.21 0.028 CID_160632 0.149 0.045 CID_160610 | ||
| 0.28 | 0.076 | 0.385 | Hypoxia-inducible factor 1 alpha inhibitor | 0.256 0.095 CID_160632 0.385 0.034 CID_160610 0.249 0.102 CID_154699869 | CID_160610 | |
| 0.206 | 0.011 | 0.322 | 5 Hydroxytryptamine uptake inhibitor | 0.322 0.005 CID_160632 0.102 0.026 CID_160610 0.114 0.022 CID_154699869 | CID_160632 | |
| 0.215 | 0.021 | 0.215 | Acetylcholine muscarinic antagonist | 0.147 0.045 CID_160632 0.197 0.025 CID_160610 0.194 0.026 CID_154699869 | ||
| 0.206 | 0.013 | 0.206 | MAP3K9 inhibitor | 0.199 0.016 CID_160632 0.197 0.017 CID_160610 0.166 0.039 CID_154699869 | ||
| 0.221 | 0.029 | 0.221 | 5 Hydroxytryptamine antagonist | 0.188 0.037 CID_160632 0.123 0.063 CID_160610 | ||
| 0.215 | 0.027 | 0.215 | Acetylcholine antagonist | 0.164 0.043 CID_160632 0.19 0.033 CID_160610 0.17 0.04 CID_154699869 | ||
| 0.295 | 0.117 | 0.363 | Calpain 2 inhibitor | 0.363 0.08 CID_160632 0.204 0.184 CID_160610 | CID_160632 | |
| 0.199 | 0.024 | 0.199 | Adrenaline antagonist | 0.186 0.026 CID_160632 0.166 0.031 CID_160610 0.111 0.048 CID_154699869 | ||
| 0.192 | 0.02 | 0.192 | Falcipain 3 inhibitor | 0.15 0.036 CID_160632 0.16 0.032 CID_160610 0.119 0.054 CID_154699869 | ||
| 0.196 | 0.028 | 0.196 | Alpha adrenoreceptor antagonist | 0.175 0.032 CID_160632 0.164 0.034 CID_160610 0.084 0.069 CID_154699869 | ||
| 0.248 | 0.08 | 0.275 | Interleukin agonist | 0.275 0.062 CID_160632 0.226 0.097 CID_160610 0.264 0.069 CID_154699869 | CID_160632 | |
| 0.187 | 0.02 | 0.22 | Adenylate cyclase stimulant | 0.22 0.007 CID_160632 0.209 0.01 CID_160610 0.193 0.017 CID_154699869 | CID_160632 | |
| 0.181 | 0.022 | 0.181 | 5 Hydroxytryptamine 2A antagonist | 0.139 0.031 CID_160632 0.111 0.042 CID_160610 | ||
| 0.18 | 0.022 | 0.18 | Calcium channel (voltage-sensitive) blocker | 0.166 0.026 CID_160632 0.108 0.073 CID_160610 | ||
| 0.16 | 0.011 | 0.16 | Histamine N-methyltransferase inhibitor | 0.126 0.026 CID_160632 0.151 0.014 CID_160610 0.102 0.044 CID_154699869 | ||
| 0.154 | 0.009 | 0.154 | Calcium channel L-type blocker | 0.15 0.01 CID_160632 0.103 0.023 CID_160610 0.081 0.038 CID_154699869 | ||
| 0.153 | 0.016 | 0.153 | 5 Hydroxytryptamine 1F antagonist | 0.093 0.035 CID_160632 0.088 0.038 CID_160610 | ||
| 0.197 | 0.063 | 0.232 | Sigma receptor agonist | 0.138 0.094 CID_160632 0.232 0.053 CID_160610 | CID_160610 | |
| 0.163 | 0.03 | 0.163 | Calcium channel N-type blocker | 0.155 0.035 CID_160632 | ||
| 0.221 | 0.089 | 0.298 | Vasodilator | 0.171 0.131 CID_160632 0.241 0.074 CID_160610 0.298 0.049 CID_154699869 | CID_154699869 | |
| 0.167 | 0.034 | 0.167 | 5 Hydroxytryptamine 2B antagonist | 0.135 0.048 CID_160632 0.123 0.058 CID_160610 | ||
| 0.143 | 0.011 | 0.143 | Interferon agonist | 0.102 0.027 CID_160632 0.115 0.019 CID_160610 0.134 0.013 CID_154699869 | ||
| 0.168 | 0.041 | 0.174 | Neuropeptide Y1 antagonist | 0.174 0.035 CID_160632 0.172 0.037 CID_160610 | CID_160632 | |
| 0.154 | 0.029 | 0.154 | Photosensitizer | 0.105 0.08 CID_160632 0.151 0.03 CID_160610 0.126 0.05 CID_154699869 | ||
| 0.141 | 0.016 | 0.27 | Dopamine D1 antagonist | 0.088 0.029 CID_160632 0.27 0.007 CID_160610 | CID_160610 | |
| 0.144 | 0.024 | 0.144 | Calcium antagonist | 0.072 0.071 CID_160632 0.073 0.07 CID_160610 | ||
| 0.133 | 0.014 | 0.133 | Acetylcholine M4 receptor antagonist | 0.102 0.027 CID_160632 0.082 0.044 CID_160610 | ||
| 0.13 | 0.012 | 0.13 | 5 Hydroxytryptamine 3 antagonist | 0.073 0.027 CID_160632 0.056 0.041 CID_154699869 | ||
| 0.136 | 0.025 | 0.219 | Alcohol dehydrogenase inhibitor | 0.107 0.046 CID_160632 0.219 0.01 CID_160610 0.12 0.035 CID_154699869 | CID_160610 | |
| 0.119 | 0.01 | 0.159 | Estrogen-related receptor beta agonist | 0.095 0.031 CID_160632 0.159 0.004 CID_160610 0.108 0.017 CID_154699869 | CID_160610 | |
| 0.198 | 0.091 | 0.198 | HERG channel blocker | 0.169 0.111 CID_154699869 | ||
| 0.21 | 0.104 | 0.21 | Calpain inhibitor | 0.206 0.108 CID_160632 0.167 0.152 CID_160610 | ||
| 0.148 | 0.043 | 0.15 | DNA intercalator | 0.15 0.042 CID_160610 0.112 0.063 CID_154699869 | CID_160610 | |
| 0.163 | 0.058 | 0.203 | GABA C receptor rho-2 antagonist | 0.203 0.027 CID_160632 0.159 0.062 CID_160610 | CID_160632 | |
| 0.189 | 0.088 | 0.249 | Neurotrophic factor enhancer | 0.207 0.07 CID_160632 0.249 0.039 CID_160610 0.201 0.076 CID_154699869 | CID_160610 | |
| 0.133 | 0.033 | 0.133 | Alpha 1 adrenoreceptor antagonist | 0.124 0.035 CID_160632 0.102 0.042 CID_160610 | ||
| 0.151 | 0.051 | 0.151 | Pregnane X receptor agonist | 0.141 0.071 CID_160632 0.144 0.065 CID_160610 0.143 0.066 CID_154699869 | ||
| 0.11 | 0.013 | 0.11 | 5 Hydroxytryptamine 5A antagonist | 0.101 0.015 CID_160632 0.084 0.021 CID_160610 | ||
| 0.118 | 0.022 | 0.161 | Histamine H2 receptor antagonist | 0.161 0.008 CID_160632 0.084 0.058 CID_160610 | CID_160632 | |
| 0.275 | 0.18 | 0.552 | Calcium channel L-type activator | 0.552 0.013 CID_160632 0.38 0.095 CID_160610 | CID_160632 | |
| 0.134 | 0.04 | 0.134 | GABA C receptor antagonist | 0.123 0.05 CID_160632 0.119 0.054 CID_160610 | ||
| 0.097 | 0.004 | 0.097 | GABA uptake inhibitor | 0.063 0.009 CID_160632 0.079 0.005 CID_160610 0.062 0.009 CID_154699869 | ||
| 0.149 | 0.056 | 0.153 | Acetylcholinesterase inhibitor | 0.109 0.091 CID_160632 0.153 0.054 CID_160610 0.116 0.082 CID_154699869 | CID_160610 | |
| 0.103 | 0.011 | 0.12 | Dopamine transporter inhibitor | 0.12 0.009 CID_160632 0.07 0.02 CID_160610 0.101 0.012 CID_154699869 | CID_160632 | |
| 0.096 | 0.008 | 0.099 | 5 Hydroxytryptamine 4 antagonist | 0.099 0.007 CID_160632 0.064 0.021 CID_160610 0.062 0.022 CID_154699869 | CID_160632 | |
| 0.133 | 0.045 | 0.154 | TRPA1 agonist | 0.129 0.049 CID_160632 0.154 0.028 CID_160610 | CID_160610 | |
| 0.099 | 0.013 | 0.099 | Interferon inducer | 0.08 0.024 CID_160632 0.078 0.025 CID_160610 0.095 0.014 CID_154699869 | ||
| 0.227 | 0.142 | 0.281 | Cholesterol antagonist | 0.281 0.104 CID_160610 0.277 0.106 CID_154699869 | CID_160610 | |
| 0.144 | 0.059 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.134 0.1 CID_160632 0.137 0.083 CID_160610 0.149 0.045 CID_154699869 | CID_154699869 | |
| 0.157 | 0.071 | 0.157 | Cholinergic | 0.121 0.106 CID_160632 0.14 0.086 CID_160610 0.137 0.088 CID_154699869 | ||
| 0.107 | 0.023 | 0.107 | CXC chemokine 4 receptor antagonist | 0.096 0.026 CID_160632 0.075 0.034 CID_160610 | ||
| 0.213 | 0.131 | 0.228 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.228 0.099 CID_160632 | CID_160632 | |
| 0.097 | 0.016 | 0.097 | 5 Hydroxytryptamine 5 antagonist | 0.091 0.017 CID_160632 0.07 0.026 CID_160610 | ||
| 0.087 | 0.006 | 0.087 | Adenylate cyclase 1 inhibitor | 0.085 0.006 CID_160632 0.074 0.01 CID_160610 0.073 0.011 CID_154699869 | ||
| 0.127 | 0.047 | 0.143 | Protein kinase C gamma inhibitor | 0.115 0.057 CID_160632 0.143 0.036 CID_160610 0.107 0.066 CID_154699869 | CID_160610 | |
| 0.186 | 0.106 | 0.186 | Potassium channel (Voltage-sensitive) blocker | 0.168 0.122 CID_154699869 | ||
| 0.124 | 0.045 | 0.124 | Butyrylcholinesterase inhibitor | 0.113 0.051 CID_160610 | ||
| 0.112 | 0.033 | 0.112 | Acetylcholine nicotinic antagonist | 0.103 0.038 CID_160632 0.084 0.051 CID_160610 | ||
| 0.158 | 0.079 | 0.178 | Arachidonic acid antagonist | 0.123 0.121 CID_160632 0.178 0.055 CID_160610 0.157 0.08 CID_154699869 | CID_160610 | |
| 0.197 | 0.118 | 0.222 | DNA damaging | 0.222 0.099 CID_160610 | CID_160610 | |
| 0.164 | 0.087 | 0.181 | Lipocortins synthesis antagonist | 0.151 0.103 CID_160632 0.181 0.07 CID_160610 0.162 0.089 CID_154699869 | CID_160610 | |
| 0.171 | 0.094 | 0.311 | Amyloid beta aggregation inhibitor | 0.311 0.043 CID_160610 0.164 0.098 CID_154699869 | CID_160610 | |
| 0.133 | 0.057 | 0.155 | Adenylate cyclase inhibitor | 0.137 0.054 CID_160632 0.155 0.042 CID_160610 0.117 0.07 CID_154699869 | CID_160610 | |
| 0.099 | 0.024 | 0.099 | 5 Hydroxytryptamine 1B antagonist | 0.081 0.034 CID_160632 0.061 0.049 CID_160610 | ||
| 0.088 | 0.013 | 0.088 | Potassium channel (Ca-activated) blocker | 0.058 0.045 CID_160632 0.061 0.039 CID_160610 | ||
| 0.117 | 0.044 | 0.141 | Protein kinase C mu inhibitor | 0.141 0.03 CID_160632 0.101 0.056 CID_160610 0.098 0.058 CID_154699869 | CID_160632 | |
| 0.081 | 0.008 | 0.081 | Antiviral (Hepatitis D) | 0.069 0.014 CID_160610 0.059 0.023 CID_154699869 | ||
| 0.195 | 0.123 | 0.252 | Immunostimulant | 0.159 0.148 CID_160632 0.216 0.111 CID_160610 0.252 0.095 CID_154699869 | CID_154699869 | |
| 0.085 | 0.013 | 0.098 | 5 Hydroxytryptamine 2 agonist | 0.098 0.01 CID_160632 0.059 0.027 CID_160610 | CID_160632 | |
| 0.221 | 0.15 | 0.221 | Ca(v)3.3 blocker | |||
| 0.12 | 0.049 | 0.128 | Alpha 2c adrenoreceptor antagonist | 0.128 0.044 CID_160632 0.11 0.057 CID_160610 | CID_160632 | |
| 0.12 | 0.049 | 0.12 | Acetylcholine release stimulant | 0.119 0.05 CID_160632 | ||
| 0.113 | 0.043 | 0.179 | Nitric-oxide synthase inhibitor | 0.179 0.014 CID_160632 0.092 0.073 CID_154699869 | CID_160632 | |
| 0.108 | 0.039 | 0.112 | Phosphodiesterase 6D inhibitor | 0.112 0.034 CID_160610 0.107 0.041 CID_154699869 | CID_160610 | |
| 0.11 | 0.041 | 0.117 | Alpha 2 adrenoreceptor antagonist | 0.117 0.038 CID_160632 0.099 0.048 CID_160610 | CID_160632 | |
| 0.093 | 0.025 | 0.093 | 5 Hydroxytryptamine 1D antagonist | 0.081 0.03 CID_160632 0.055 0.054 CID_160610 | ||
| 0.092 | 0.027 | 0.092 | Dopamine D3 antagonist | 0.061 0.044 CID_160632 0.076 0.034 CID_160610 | ||
| 0.109 | 0.044 | 0.16 | Glutamate (mGluR7) agonist | 0.16 0.009 CID_160632 | CID_160632 | |
| 0.145 | 0.082 | 0.152 | Diuretic | 0.151 0.077 CID_160632 0.127 0.097 CID_160610 0.152 0.076 CID_154699869 | CID_154699869 | |
| 0.101 | 0.038 | 0.101 | Dopamine antagonist | 0.068 0.056 CID_160632 0.101 0.038 CID_160610 | ||
| 0.07 | 0.009 | 0.07 | 5 Hydroxytryptamine 3B antagonist | 0.058 0.012 CID_160632 | ||
| 0.204 | 0.145 | 0.204 | 5 Hydroxytryptamine uptake stimulant | 0.202 0.148 CID_160632 0.2 0.152 CID_160610 | ||
| 0.206 | 0.148 | 0.224 | Insulysin inhibitor | 0.224 0.123 CID_160632 0.215 0.136 CID_160610 | CID_160632 | |
| 0.074 | 0.016 | 0.074 | Prolactin release inhibitor | 0.065 0.034 CID_160632 0.073 0.018 CID_160610 0.068 0.027 CID_154699869 | ||
| 0.094 | 0.038 | 0.112 | Glycine receptor antagonist | 0.083 0.052 CID_160632 0.073 0.068 CID_160610 0.112 0.023 CID_154699869 | CID_154699869 | |
| 0.112 | 0.056 | 0.128 | Mediator release inhibitor | 0.121 0.047 CID_160632 0.128 0.041 CID_160610 0.093 0.078 CID_154699869 | CID_160610 | |
| 0.082 | 0.027 | 0.092 | Cannabinoid CB1 receptor agonist | 0.092 0.022 CID_160632 | CID_160632 | |
| 0.097 | 0.042 | 0.097 | Neuropeptide Y antagonist | 0.084 0.052 CID_160632 | ||
| 0.072 | 0.017 | 0.072 | 5 Hydroxytryptamine 7 agonist | 0.064 0.025 CID_160632 0.071 0.018 CID_160610 | ||
| 0.087 | 0.032 | 0.087 | CXC chemokine receptor antagonist | 0.065 0.057 CID_160610 | ||
| 0.138 | 0.084 | 0.138 | Thiol protease inhibitor | 0.126 0.105 CID_160632 | ||
| 0.078 | 0.024 | 0.085 | Protein kinase C eta inhibitor | 0.077 0.025 CID_160632 0.085 0.022 CID_160610 0.072 0.027 CID_154699869 | CID_160610 | |
| 0.099 | 0.045 | 0.099 | Glutamate release inhibitor | 0.097 0.048 CID_160632 0.087 0.069 CID_160610 | ||
| 0.081 | 0.028 | 0.081 | Protein kinase C beta inhibitor | 0.075 0.038 CID_160632 0.08 0.03 CID_160610 0.073 0.043 CID_154699869 | ||
| 0.137 | 0.085 | 0.137 | Sphingosine 1-phosphate receptor 5 antagonist | 0.125 0.111 CID_160610 | ||
| 0.08 | 0.028 | 0.08 | Glutamate (mGluR7) antagonist | 0.063 0.056 CID_160632 0.075 0.034 CID_160610 | ||
| 0.06 | 0.009 | 0.068 | Histamine H1 receptor agonist | 0.068 0.005 CID_160632 | CID_160632 | |
| 0.061 | 0.012 | 0.061 | Benzodiazepine antagonist | |||
| 0.171 | 0.122 | 0.257 | Antiamyloidogenic | 0.174 0.119 CID_160632 0.257 0.068 CID_160610 | CID_160610 | |
| 0.056 | 0.008 | 0.056 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.034 0.03 CID_160632 0.043 0.018 CID_160610 0.051 0.011 CID_154699869 | ||
| 0.058 | 0.01 | 0.058 | Phosphodiesterase 6C inhibitor | 0.05 0.021 CID_160632 0.053 0.017 CID_160610 0.048 0.027 CID_154699869 | ||
| 0.072 | 0.026 | 0.075 | Acetylcholine muscarinic agonist | 0.049 0.045 CID_160632 0.075 0.024 CID_154699869 | CID_154699869 | |
| 0.149 | 0.103 | 0.183 | ATPase inhibitor | 0.183 0.055 CID_160632 0.149 0.103 CID_160610 0.145 0.111 CID_154699869 | CID_160632 | |
| 0.067 | 0.021 | 0.067 | Chemokine receptor agonist | 0.042 0.041 CID_160632 | ||
| 0.081 | 0.035 | 0.096 | Cannabinoid receptor agonist | 0.096 0.027 CID_160632 | CID_160632 | |
| 0.088 | 0.042 | 0.101 | CC chemokine 5 receptor agonist | 0.08 0.064 CID_160632 0.101 0.021 CID_160610 | CID_160610 | |
| 0.073 | 0.027 | 0.073 | 5 Hydroxytryptamine 6 antagonist | 0.062 0.035 CID_160632 | ||
| 0.071 | 0.027 | 0.071 | Corticotropin releasing factor 2 receptor antagonist | 0.067 0.033 CID_160632 | ||
| 0.081 | 0.038 | 0.084 | Vanilloid 4 agonist | 0.084 0.033 CID_160632 0.07 0.064 CID_154699869 | CID_160632 | |
| 0.132 | 0.089 | 0.132 | Cytidine deaminase inhibitor | |||
| 0.085 | 0.042 | 0.114 | Analgesic, opioid | 0.114 0.025 CID_160610 0.092 0.036 CID_154699869 | CID_160610 | |
| 0.148 | 0.106 | 0.173 | Neurotensin receptor agonist | 0.161 0.077 CID_160632 0.173 0.058 CID_160610 | CID_160610 | |
| 0.084 | 0.045 | 0.092 | Alpha 2a adrenoreceptor antagonist | 0.092 0.041 CID_160632 0.083 0.046 CID_160610 | CID_160632 | |
| 0.069 | 0.031 | 0.097 | Androgen agonist | 0.057 0.046 CID_160632 0.088 0.02 CID_160610 0.097 0.016 CID_154699869 | CID_154699869 | |
| 0.086 | 0.049 | 0.086 | Caspase 7 inhibitor | 0.081 0.06 CID_160632 | ||
| 0.051 | 0.014 | 0.051 | Nociceptin (N/OFQ) receptor antagonist | 0.045 0.018 CID_160632 0.037 0.023 CID_160610 0.03 0.028 CID_154699869 | ||
| 0.085 | 0.048 | 0.085 | Ca(v)3.1 blocker | 0.081 0.058 CID_160610 | ||
| 0.069 | 0.032 | 0.069 | Acetylcholine M5 receptor antagonist | 0.056 0.048 CID_160632 0.056 0.048 CID_160610 | ||
| 0.12 | 0.083 | 0.176 | NADPH oxidase inhibitor | 0.176 0.042 CID_160610 0.114 0.091 CID_154699869 | CID_160610 | |
| 0.044 | 0.009 | 0.044 | Phosphodiesterase 6B inhibitor | 0.034 0.016 CID_160632 0.035 0.016 CID_160610 0.03 0.022 CID_154699869 | ||
| 0.08 | 0.045 | 0.095 | Alpha 1a adrenoreceptor antagonist | 0.095 0.038 CID_160632 | CID_160632 | |
| 0.067 | 0.032 | 0.067 | Dopamine uptake inhibitor | 0.055 0.043 CID_160632 0.063 0.035 CID_154699869 | ||
| 0.093 | 0.059 | 0.123 | Protein kinase C zeta inhibitor | 0.123 0.031 CID_160610 | CID_160610 | |
| 0.098 | 0.064 | 0.126 | GABA C receptor rho-1 antagonist | 0.126 0.035 CID_160632 | CID_160632 | |
| 0.189 | 0.155 | 0.202 | Transcription factor STAT inhibitor | 0.178 0.171 CID_160632 0.202 0.136 CID_160610 | CID_160610 | |
| 0.07 | 0.037 | 0.07 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.064 | 0.033 | 0.064 | Calcium channel T-type blocker | 0.057 0.041 CID_160632 | ||
| 0.053 | 0.022 | 0.053 | Cytokine production stimulant | 0.049 0.03 CID_160632 | ||
| 0.059 | 0.028 | 0.076 | 5 Hydroxytryptamine 1B agonist | 0.076 0.014 CID_160632 0.048 0.047 CID_160610 | CID_160632 | |
| 0.059 | 0.029 | 0.076 | Thromboxane synthase inhibitor | 0.076 0.014 CID_160632 0.053 0.04 CID_160610 0.054 0.038 CID_154699869 | CID_160632 | |
| 0.068 | 0.038 | 0.068 | Acetylcholine M2 receptor antagonist | 0.053 0.052 CID_160610 | ||
| 0.074 | 0.045 | 0.091 | Phospholipase D inhibitor | 0.091 0.021 CID_160632 | CID_160632 | |
| 0.079 | 0.05 | 0.079 | Viral attachment inhibitor | |||
| 0.063 | 0.035 | 0.063 | Phosphodiesterase 1A inhibitor | |||
| 0.133 | 0.105 | 0.141 | Heat shock protein 70 antagonist | 0.141 0.071 CID_160610 | CID_160610 | |
| 0.087 | 0.06 | 0.13 | Opioid antagonist | 0.086 0.062 CID_160632 0.13 0.032 CID_160610 0.083 0.065 CID_154699869 | CID_160610 | |
| 0.084 | 0.057 | 0.101 | Protein kinase A inhibitor | 0.101 0.045 CID_160632 | CID_160632 | |
| 0.079 | 0.052 | 0.091 | Na+ K+ transporting ATPase inhibitor | 0.081 0.049 CID_160610 0.091 0.04 CID_154699869 | CID_154699869 | |
| 0.065 | 0.039 | 0.065 | Calcium channel P-type blocker | |||
| 0.064 | 0.038 | 0.1 | Alpha 2 adrenoreceptor agonist | 0.1 0.014 CID_160632 | CID_160632 | |
| 0.106 | 0.08 | 0.132 | Cholesterol synthesis inhibitor | 0.132 0.055 CID_160610 0.126 0.06 CID_154699869 | CID_160610 | |
| 0.07 | 0.045 | 0.07 | Protein kinase C alpha inhibitor | 0.065 0.051 CID_160632 | ||
| 0.069 | 0.044 | 0.069 | Dopamine D2 antagonist | 0.069 0.045 CID_160610 | ||
| 0.039 | 0.015 | 0.039 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.04 | 0.016 | 0.04 | CXC chemokine receptor agonist | |||
| 0.106 | 0.082 | 0.128 | Alkylator | 0.122 0.066 CID_160610 0.128 0.061 CID_154699869 | CID_154699869 | |
| 0.052 | 0.029 | 0.056 | Histamine H4 receptor antagonist | 0.056 0.023 CID_160632 | CID_160632 | |
| 0.068 | 0.046 | 0.068 | Acetylcholine M5 receptor agonist | |||
| 0.03 | 0.008 | 0.03 | Phosphodiesterase 6G inhibitor | 0.024 0.015 CID_160632 0.025 0.013 CID_160610 0.022 0.02 CID_154699869 | ||
| 0.03 | 0.008 | 0.03 | Phosphodiesterase 6H inhibitor | 0.024 0.015 CID_160632 0.025 0.013 CID_160610 0.022 0.02 CID_154699869 | ||
| 0.072 | 0.05 | 0.088 | Glycine receptor agonist | 0.088 0.03 CID_154699869 | CID_154699869 | |
| 0.028 | 0.009 | 0.028 | Phosphodiesterase 6A inhibitor | 0.023 0.017 CID_160632 0.023 0.018 CID_160610 | ||
| 0.037 | 0.018 | 0.037 | Adenosine uptake inhibitor | 0.034 0.028 CID_160632 | ||
| 0.105 | 0.087 | 0.131 | Sphingosine 1-phosphate receptor 2 agonist | 0.12 0.054 CID_160632 0.107 0.081 CID_160610 0.131 0.041 CID_154699869 | CID_154699869 | |
| 0.112 | 0.095 | 0.172 | Toll-Like receptor 9 antagonist | 0.172 0.05 CID_160632 | CID_160632 | |
| 0.09 | 0.073 | 0.098 | Lanosterol 14 alpha demethylase inhibitor | 0.098 0.059 CID_160632 0.094 0.066 CID_154699869 | CID_160632 | |
| 0.026 | 0.009 | 0.026 | Apolipoprotein B inhibitor | 0.021 0.012 CID_160632 | ||
| 0.054 | 0.038 | 0.069 | Cannabinoid CB2 receptor agonist | 0.069 0.029 CID_160632 | CID_160632 | |
| 0.078 | 0.062 | 0.11 | Opioid kappa receptor antagonist | 0.088 0.048 CID_160632 0.11 0.028 CID_160610 | CID_160610 | |
| 0.15 | 0.135 | 0.165 | Potassium channel blocker | 0.165 0.12 CID_154699869 | CID_154699869 | |
| 0.02 | 0.006 | 0.02 | CXC chemokine 4 receptor agonist | 0.017 0.008 CID_160632 | ||
| 0.038 | 0.024 | 0.041 | Kinesin antagonist | 0.041 0.021 CID_160610 | CID_160610 | |
| 0.038 | 0.024 | 0.041 | Kinesin-like protein 1 inhibitor | 0.041 0.021 CID_160610 | CID_160610 | |
| 0.095 | 0.083 | 0.095 | GABA receptor agonist | |||
| 0.105 | 0.092 | 0.111 | Transcription factor STAT6 inhibitor | 0.106 0.089 CID_160632 0.111 0.077 CID_160610 | CID_160610 | |
| 0.049 | 0.036 | 0.052 | Squalene epoxidase inhibitor | 0.052 0.03 CID_160610 | CID_160610 | |
| 0.115 | 0.103 | 0.154 | Neurotrophic factor | 0.115 0.104 CID_160610 0.154 0.055 CID_154699869 | CID_154699869 | |
| 0.03 | 0.019 | 0.03 | 5 Hydroxytryptamine 1D agonist | |||
| 0.034 | 0.023 | 0.039 | Growth hormone releasing factor agonist | 0.039 0.019 CID_160632 | CID_160632 | |
| 0.058 | 0.049 | 0.073 | 5 Hydroxytryptamine 2A agonist | 0.073 0.034 CID_160632 0.055 0.052 CID_160610 | CID_160632 | |
| 0.02 | 0.011 | 0.02 | Apolipoprotein B-100 inhibitor | 0.017 0.015 CID_160632 | ||
| 0.177 | 0.168 | 0.184 | Transcription factor STAT3 inhibitor | 0.184 0.158 CID_160610 | CID_160610 | |
| 0.106 | 0.097 | 0.107 | Cathepsin H inhibitor | 0.107 0.094 CID_160632 | CID_160632 | |
| 0.026 | 0.017 | 0.03 | Acid ceramidase inhibitor | 0.03 0.009 CID_160632 | CID_160632 | |
| 0.04 | 0.032 | 0.055 | Dopamine D5 antagonist | 0.055 0.022 CID_160610 | CID_160610 | |
| 0.139 | 0.131 | 0.155 | Non-steroidal antiinflammatory agent | 0.155 0.109 CID_160610 | CID_160610 | |
| 0.053 | 0.045 | 0.063 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 CID_160632 | CID_160632 | |
| 0.026 | 0.019 | 0.026 | Urotensin II agonist | 0.024 0.022 CID_160610 | ||
| 0.028 | 0.021 | 0.035 | Estrogen-related receptor gamma antagonist | 0.035 0.008 CID_160610 | CID_160610 | |
| 0.064 | 0.057 | 0.078 | Alpha 1b adrenoreceptor antagonist | 0.078 0.048 CID_160632 | CID_160632 | |
| 0.071 | 0.065 | 0.127 | Estrogen receptor alpha antagonist | 0.127 0.016 CID_160610 0.078 0.052 CID_154699869 | CID_160610 | |
| 0.049 | 0.043 | 0.054 | Acyl-CoA dehydrogenase inhibitor | 0.054 0.038 CID_154699869 | CID_154699869 | |
| 0.065 | 0.059 | 0.065 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.04 | 0.034 | 0.058 | Dopamine D2 agonist | 0.058 0.022 CID_160610 | CID_160610 | |
| 0.028 | 0.024 | 0.03 | Peptide deformylase inhibitor | 0.03 0.022 CID_160632 | CID_160632 | |
| 0.182 | 0.177 | 0.19 | Thyroid hormone antagonist | 0.19 0.17 CID_160610 | CID_160610 | |
| 0.142 | 0.138 | 0.154 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.154 0.123 CID_160632 | CID_160632 | |
| 0.051 | 0.048 | 0.058 | Alpha 1d adrenoreceptor antagonist | 0.058 0.042 CID_160632 | CID_160632 | |
| 0.024 | 0.021 | 0.024 | Sigma 2 receptor antagonist | 0.023 0.021 CID_160610 | ||
| 0.038 | 0.035 | 0.04 | Acetylcholine M1 receptor agonist | 0.04 0.032 CID_154699869 | CID_154699869 | |
| 0.17 | 0.168 | 0.178 | DNA synthesis inhibitor | 0.173 0.164 CID_160610 0.178 0.156 CID_154699869 | CID_154699869 | |
| 0.057 | 0.055 | 0.08 | Dopamine agonist | 0.08 0.037 CID_160610 | CID_160610 | |
| 0.028 | 0.026 | 0.037 | Endothelial nitric-oxide synthase inhibitor | 0.037 0.016 CID_160632 | CID_160632 | |
| 0.068 | 0.066 | 0.074 | GABA aminotransferase inhibitor | 0.074 0.054 CID_160610 | CID_160610 | |
| 0.026 | 0.026 | 0.027 | Acetylcholine M4 receptor agonist | 0.027 0.024 CID_154699869 | CID_154699869 | |
| 0.085 | 0.085 | 0.137 | Gastric antisecretory | 0.137 0.033 CID_154699869 | CID_154699869 | |
| 0.056 | 0.055 | 0.056 | Bcl-xL inhibitor | 0.056 0.055 CID_160610 | ||
| 0.137 | 0.138 | 0.148 | Succinate dehydrogenase inhibitor | 0.148 0.117 CID_160610 | CID_160610 | |
| 0.079 | 0.079 | 0.08 | Granulocyte macrophage colony stimulating factor agonist | 0.08 0.075 CID_160632 0.08 0.075 CID_160610 | CID_160610 | |
| 0.059 | 0.06 | 0.076 | Beta 3 adrenoreceptor antagonist | 0.063 0.047 CID_160632 0.076 0.027 CID_160610 | CID_160610 | |
| 0.057 | 0.059 | 0.133 | Alpha adrenoreceptor agonist | 0.133 0.019 CID_160632 | CID_160632 | |
| 0.03 | 0.032 | 0.041 | RNA-directed RNA polymerase inhibitor | 0.041 0.018 CID_160632 0.035 0.022 CID_160610 | CID_160632 | |
| 0.038 | 0.04 | 0.039 | Geranyltranstransferase inhibitor | 0.039 0.038 CID_160632 | CID_160632 | |
| 0.053 | 0.056 | 0.066 | NMDA 2C receptor antagonist | 0.066 0.037 CID_160610 | CID_160610 | |
| 0.083 | 0.086 | 0.099 | Interleukin 1 beta converting enzyme inhibitor | 0.099 0.058 CID_160632 | CID_160632 | |
| 0.098 | 0.101 | 0.117 | Interleukin 8 antagonist | 0.117 0.065 CID_160632 0.11 0.076 CID_160610 | CID_160632 | |
| 0.062 | 0.066 | 0.064 | Aminopeptidase I inhibitor | 0.064 0.062 CID_160632 | CID_160632 | |
| 0.012 | 0.016 | 0.015 | NMDA receptor phencyclidine site antagonist | 0.015 0.011 CID_160610 | CID_160610 | |
| 0.016 | 0.021 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 CID_160610 | CID_160610 | |
| 0.095 | 0.1 | 0.103 | Microtubule formation inhibitor | 0.103 0.085 CID_154699869 | CID_154699869 | |
| 0.03 | 0.036 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.029 CID_160610 | CID_160610 | |
| 0.038 | 0.044 | 0.041 | Potassium channel small-conductance Ca-activated blocker | 0.041 0.039 CID_160632 | CID_160632 | |
| 0.024 | 0.03 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.021 CID_160632 | CID_160632 | |
| 0.047 | 0.053 | 0.06 | Nicotinic alpha3beta2 receptor antagonist | 0.06 0.026 CID_160632 | CID_160632 | |
| 0.01 | 0.018 | 0.016 | Melatonin receptor 1A antagonist | 0.016 0.007 CID_160632 | CID_160632 | |
| 0.025 | 0.033 | 0.035 | HCV NS5B polymerase inhibitor | 0.035 0.018 CID_160610 | CID_160610 | |
| 0.107 | 0.115 | 0.273 | Peroxidase inhibitor | 0.273 0.043 CID_160610 | CID_160610 | |
| 0.079 | 0.088 | 0.15 | Creatine kinase inhibitor | 0.15 0.024 CID_160610 0.089 0.074 CID_154699869 | CID_160610 | |
| 0.009 | 0.019 | 0.011 | Melatonin 2 antagonist | 0.011 0.01 CID_160632 | CID_160632 | |
| 0.035 | 0.045 | 0.047 | Histamine H2 receptor agonist | 0.047 0.024 CID_160632 | CID_160632 | |
| 0.082 | 0.093 | 0.103 | Anabolic | 0.103 0.059 CID_160610 0.096 0.069 CID_154699869 | CID_160610 | |
| 0.108 | 0.119 | 0.141 | Vanilloid 1 agonist | 0.141 0.049 CID_160632 0.119 0.089 CID_160610 | CID_160632 | |
| 0.032 | 0.043 | 0.062 | Dopamine D5 agonist | 0.062 0.011 CID_160610 | CID_160610 | |
| 0.029 | 0.044 | 0.052 | Alpha 1d adrenoreceptor agonist | 0.052 0.015 CID_160632 | CID_160632 | |
| 0.023 | 0.039 | 0.029 | Hedgehog signaling activator | 0.029 0.016 CID_154699869 | CID_154699869 | |
| 0.04 | 0.056 | 0.052 | Topoisomerase II beta inhibitor | 0.052 0.03 CID_160610 | CID_160610 | |
| 0.031 | 0.048 | 0.044 | Liver X receptor alpha agonist | 0.044 0.025 CID_160610 | CID_160610 | |
| 0.041 | 0.059 | 0.065 | Histamine agonist | 0.065 0.023 CID_160632 | CID_160632 | |
| 0.01 | 0.029 | 0.021 | Growth hormone release promoting | 0.021 0.013 CID_160632 | CID_160632 | |
| 0.029 | 0.049 | 0.038 | Delayed rectifier potassium channel blocker | 0.038 0.024 CID_160632 | CID_160632 | |
| 0.033 | 0.054 | 0.053 | Cannabinoid CB2 receptor antagonist | 0.053 0.035 CID_160632 | CID_160632 | |
| 0.154 | 0.176 | 0.171 | MAP-kinase-activated kinase 5 inhibitor | 0.171 0.146 CID_160632 0.166 0.156 CID_160610 | CID_160632 | |
| 0.196 | 0.22 | 0.295 | Calcium channel activator | 0.295 0.097 CID_160632 | CID_160632 | |
| 0.012 | 0.037 | 0.028 | Dopamine autoreceptor agonist | 0.028 0.014 CID_160632 | CID_160632 | |
| 0.02 | 0.047 | 0.049 | Vasopressin 2 antagonist | 0.049 0.014 CID_154699869 | CID_154699869 | |
| 0.046 | 0.074 | 0.089 | Opioid mu receptor antagonist | 0.089 0.036 CID_160610 | CID_160610 | |
| 0.052 | 0.084 | 0.063 | Histone deacetylase SIRT3 inhibitor | 0.063 0.04 CID_160632 | CID_160632 | |
| 0.127 | 0.162 | 0.148 | Phospholipase C inhibitor | 0.148 0.111 CID_160610 | CID_160610 | |
| 0.059 | 0.094 | 0.078 | Ca(v)2.2 blocker | 0.078 0.067 CID_160632 | CID_160632 | |
| 0.087 | 0.125 | 0.114 | Cyclooxygenase 3 inhibitor | 0.114 0.084 CID_160610 | CID_160610 | |
| 0.036 | 0.075 | 0.051 | Baculoviral IAP repeat-containing protein inhibitor | 0.051 0.018 CID_160632 | CID_160632 | |
| 0.088 | 0.129 | 0.168 | Estrogen antagonist | 0.168 0.018 CID_160610 0.11 0.076 CID_154699869 | CID_160610 | |
| 0.035 | 0.076 | 0.08 | Opioid delta receptor antagonist | 0.08 0.036 CID_160610 | CID_160610 | |
| 0.018 | 0.06 | 0.036 | Antidiuretic hormone antagonist | 0.036 0.03 CID_154699869 | CID_154699869 | |
| 0.139 | 0.181 | 0.17 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.17 0.108 CID_160610 | CID_160610 | |
| 0.074 | 0.117 | 0.093 | Bile acid receptor antagonist | 0.093 0.066 CID_160610 | CID_160610 | |
| 0.052 | 0.099 | 0.071 | Secretase beta inhibitor | 0.071 0.048 CID_160632 | CID_160632 | |
| 0.077 | 0.124 | 0.092 | Nav1.4 sodium channel blocker | 0.092 0.09 CID_160610 | CID_160610 | |
| 0.018 | 0.067 | 0.029 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.029 0.026 CID_160610 | CID_160610 | |
| 0.059 | 0.11 | 0.085 | Antineoplastic alkaloid | 0.084 0.061 CID_160610 0.085 0.059 CID_154699869 | CID_154699869 | |
| 0.054 | 0.107 | 0.076 | Androgen antagonist | 0.076 0.071 CID_160610 | CID_160610 | |
| 0.047 | 0.102 | 0.083 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.083 0.049 CID_160610 | CID_160610 | |
| 0.033 | 0.09 | 0.064 | Alpha 1 adrenoreceptor agonist | 0.064 0.032 CID_160632 | CID_160632 | |
| 0.089 | 0.149 | 0.15 | Protein kinase stimulant | 0.114 0.099 CID_160610 0.15 0.068 CID_154699869 | CID_154699869 | |
| 0.021 | 0.087 | 0.043 | Estrogen-related receptor beta antagonist | 0.043 0.009 CID_160610 | CID_160610 | |
| 0.035 | 0.107 | 0.064 | Bombesin 1 receptor agonist | 0.064 0.036 CID_160632 | CID_160632 | |
| 0.084 | 0.157 | 0.128 | Protein kinase C nu inhibitor | 0.128 0.084 CID_154699869 | CID_154699869 | |
| 0.063 | 0.145 | 0.097 | Carbonic anhydrase III inhibitor | 0.097 0.066 CID_160610 | CID_160610 | |
| 0.076 | 0.162 | 0.122 | Toll-Like receptor 2 antagonist | 0.122 0.075 CID_160610 | CID_160610 | |
| 0.046 | 0.134 | 0.082 | MAO A inhibitor | 0.082 0.079 CID_160610 | CID_160610 | |
| 0.132 | 0.221 | 0.168 | Superoxide dismutase inhibitor | 0.168 0.159 CID_160610 | CID_160610 | |
| 0.015 | 0.104 | 0.044 | Estradiol 17 beta-dehydrogenase inhibitor | 0.044 0.028 CID_160610 | CID_160610 | |
| 0.026 | 0.119 | 0.051 | Beta 1 adrenoreceptor antagonist | 0.051 0.045 CID_160632 | CID_160632 | |
| 0.073 | 0.166 | 0.17 | Lipid peroxidase inhibitor | 0.17 0.056 CID_160610 | CID_160610 | |
| 0.096 | 0.189 | 0.13 | Amyloid beta precursor protein antagonist | 0.13 0.127 CID_160610 | CID_160610 | |
| 0.072 | 0.17 | 0.104 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.104 0.099 CID_160632 | CID_160632 | |
| 0.049 | 0.15 | 0.088 | Inducible nitric-oxide synthase inhibitor | 0.088 0.05 CID_160632 | CID_160632 | |
| 0.035 | 0.136 | 0.059 | Beta adrenoreceptor antagonist | 0.059 0.058 CID_160632 | CID_160632 | |
| 0.047 | 0.149 | 0.111 | Topoisomerase I inhibitor | 0.111 0.062 CID_160610 | CID_160610 | |
| 0.056 | 0.162 | 0.078 | MAP kinase kinase 7 inhibitor | 0.078 0.053 CID_160610 | CID_160610 | |
| 0.154 | 0.261 | 0.289 | Sodium/bile acid cotransporter inhibitor | 0.289 0.089 CID_160610 0.247 0.131 CID_154699869 | CID_160610 | |
| 0.105 | 0.219 | 0.141 | MAP kinase kinase 4 inhibitor | 0.141 0.082 CID_160610 | CID_160610 | |
| 0.034 | 0.148 | 0.073 | Nicotinic alpha4beta2 receptor antagonist | 0.073 0.058 CID_160632 | CID_160632 | |
| 0.033 | 0.149 | 0.078 | Factor III inhibitor | 0.078 0.008 CID_160632 | CID_160632 | |
| 0.067 | 0.184 | 0.101 | DOPA decarboxylase inhibitor | 0.101 0.074 CID_160610 | CID_160610 | |
| 0.156 | 0.282 | 0.309 | Interleukin 2 agonist | 0.212 0.169 CID_160610 0.309 0.068 CID_154699869 | CID_154699869 | |
| 0.087 | 0.231 | 0.13 | Melanin inhibitor | 0.13 0.115 CID_160610 | CID_160610 | |
| 0.009 | 0.153 | 0.067 | Estrogen agonist | 0.067 0.027 CID_160610 | CID_160610 | |
| 0.088 | 0.233 | 0.165 | I kappa B kinase epsilon inhibitor | 0.165 0.104 CID_160632 | CID_160632 | |
| 0.004 | 0.153 | 0.035 | Estrogen receptor alpha agonist | 0.035 0.023 CID_160610 | CID_160610 | |
| 0.042 | 0.208 | 0.111 | Topoisomerase II inhibitor | 0.111 0.075 CID_160610 | CID_160610 | |
| 0.077 | 0.244 | 0.134 | NOS3 expression enhancer | 0.134 0.091 CID_160610 | CID_160610 | |
| 0.134 | 0.314 | 0.287 | Apoptosis antagonist | 0.199 0.181 CID_160610 0.287 0.095 CID_154699869 | CID_154699869 | |
| 0.054 | 0.243 | 0.17 | Toll-Like receptor 3 antagonist | 0.17 0.01 CID_160632 | CID_160632 | |
| 0.114 | 0.311 | 0.239 | Immunosuppressant | 0.239 0.157 CID_154699869 | CID_154699869 | |
| 0.072 | 0.272 | 0.146 | Nitric oxide antagonist | 0.132 0.116 CID_160610 0.146 0.098 CID_154699869 | CID_154699869 | |
| 0.043 | 0.245 | 0.128 | Estrogen receptor beta antagonist | 0.128 0.025 CID_160610 | CID_160610 | |
| 0.019 | 0.225 | 0.059 | NMDA 2B receptor antagonist | 0.059 0.032 CID_154699869 | CID_154699869 | |
| 0.126 | 0.343 | 0.229 | Antibacterial | 0.229 0.197 CID_154699869 | CID_154699869 | |
| 0.043 | 0.318 | 0.082 | Vanilloid agonist | 0.082 0.064 CID_160632 | CID_160632 | |
| 0.059 | 0.359 | 0.154 | Hepatoprotectant | 0.154 0.106 CID_154699869 | CID_154699869 | |
| 0.103 | 0.408 | 0.199 | Peptidyltransferase inhibitor | 0.199 0.1 CID_160632 0.177 0.134 CID_154699869 | CID_160632 | |
| 0.084 | 0.414 | 0.262 | Immunomodulator | 0.262 0.106 CID_154699869 | CID_154699869 | |
| 0.034 | 0.437 | 0.154 | Hypolipemic | 0.154 0.133 CID_154699869 | CID_154699869 | |
| 0.03 | 0.454 | 0.094 | DNA polymerase I inhibitor | 0.094 0.092 CID_154699869 | CID_154699869 | |
| 0.1 | 0.529 | 0.381 | Antiinflammatory | 0.381 0.151 CID_154699869 | CID_154699869 | |
| 0.038 | 0.484 | 0.177 | Antioxidant | 0.177 0.135 CID_160610 | CID_160610 | |
| 0.021 | 0.555 | 0.159 | Free radical scavenger | 0.159 0.135 CID_160610 | CID_160610 | |
| 0.06 | 0.6 | 0.194 | Caspase 3 stimulant | 0.194 0.179 CID_154699869 | CID_154699869 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |